Effect of Triamcinolone Acetonide on Vascular Endothelial Growth Factor and Occludin Levels in Branch Retinal Vein Occlusion

American Journal of Ophthalmology

Volumn 147, Issue 5, 2009, Pages

  McAllister, Ian L ^a   Vijayasekaran, Sarojini ^a   Chen, Simon D ^a   Yu, Dao Yi ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; OCCLUDIN; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CONTROLLED STUDY; EYE; FLUORESCENCE ANGIOGRAPHY; IMMUNOCYTOCHEMISTRY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA EDEMA; STEROID THERAPY; SWINE; TREATMENT OUTCOME;

EID: 64449083096     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.12.006     Document Type: Article

References (45)

1. Jonas J.B., Kreissig I., and Degenring R.F. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240 (2002) 782-783
2. Chen S.D.M., Lochhead J., Patel C.K., and Frith P. Intravitreal triamcinolone acetonide for ischemic macular edema caused by branch retinal vein occlusion. Br J Ophthalmol 88 (2004) 154-155
3. Jonas J.B., Hayler J.K., Sofker A., and Panda-Jonas S. Intravitreal injection of crystalline cortisone and adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 131 (2001) 468-471
4. Wilson C.A., Berkowitz B.A., Sato Y., et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110 (1992) 1155-1159
5. Hoheisel D., Nitz T., Franke H., et al. Hydrocortisone reinforces the blood brain-barrier properties in a serum free cell culture system. Biochem Biophys Res Commun 244 (1998) 312-316
6. Engler C.B., Sander B., Larsen M., et al. Probenecid inhibition of the outward transport of fluorescein across the human blood-retinal barrier. Acta Ophthalmologica 72 (1994) 663-667
7. Aiello L.P., Northrup J.M., Keyt B.A., et al. Hypoxia regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113 (1995) 1538-1554
8. Murata T., Nakagawa K., Khalil A., et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74 (1996) 819-825
9. Antonetti D.A., Barber A.J., Khin S., et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content. Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47 (1998) 1953-1959
10. Lieth E., Barber A.J., Xu B., et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47 (1998) 815-820
11. Barber A.J., Antonetti D.A., Gardner T.W., and Penn State Retina Group. Altered expression of Retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 41 (2000) 3561-3568
12. McAllister I.L., Yu D.-Y., Vijayasekaran S., et al. Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion. Br J Ophthlamol 76 (1992) 615-620
13. Vijayasekaran S., Yu D.-Y., McAllister I.L., et al. Significance of Bruch's membrane in the creation of iatrogenic chorioretinal venous anastomosis. Curr Eye Res 13 (1994) 29-33
14. Danis R.P., Yang Y., Massicotte S.J., and Boldt H.C. Retinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs. Arch Ophthalmol 111 (1993) 539-543
15. Penfold P.L., Wen L., Madigan M.C., et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of ECV304 cell line: implications for macular degeneration. Clin Exp Immunol 121 (2000) 458-465
16. Claesson-Welsh L. Signal transduction by vascular endothelia growth factor receptors. Biochem Soc Trans 31 (2003) 20-24
17. Keyt B.A., Berleau L.T., Nguyen H.V., et al. The carboxyl terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271 (1996) 7788-7795
18. Adamis A.P., Shima D.T., Yeo K.T., et al. Synthesis and secretion of vascular permeability factor/vascular endothelial factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun 193 (1993) 631-638
19. Pe'er J., Shweiki D., Itin A., et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72 (1995) 638-645
20. Miller J.W., Adamis A.P., Shima D.T., et al. Vascular endothelial growth factor/vascular permeability factor is temporarily and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145 (1994) 574-584
21. Stone J., Itin A., Alon T., et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial factor (VEGF) expression by neuroglia. J Neurosci 15 (1995) 4738-4747
22. Murata T., Ishibashi T., Kalil A., et al. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27 (1995) 48-52
23. Ishibashi T., Hata Y., Yoshikawa H., et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 235 (1997) 159-167
24. Lutty G.A., McLeod S., Merges C., et al. Localisation of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114 (1996) 971-977
25. Brown L.F., Yeo K.-T., Berse B., et al. Expression of vascular permeability factor (vascular endothelial factor) by epidermal keratinocytes during wound healing. J Exp Med 176 (1992) 1375-1379
26. Sunderkotter C., Steinbrink K., Goebeler M., et al. Macrophages and angiogenesis. J Leukoc Biol 55 (1994) 410-422
27. Jonas J.B. Concentration of intravitreally injected triamcinolone acetonide in aqueous humour. Br J Ophthalmol 86 (2002) 1066-1068
28. Ehrenberg M., Brooks W., McCuen I.I., et al. Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids. Ophthalmology 91 (1984) 321-326
29. Edelman J.L., Lutz D., and Castro M.R. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80 (2005) 249-258
30. Antonetti D.A., Barber A.J., Hollinger L.A., et al. Vascular endothelial growth factor induces phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274 (1999) 23463-23467
31. Antonetti D.A., Wolpert E.B., DeMaio L., et al. Hydrocortisone decreases retinal and endothelial cell water and solute flux coincident wtth increased content and decreased phosphorylation of occludin. J Neurochem 80 (2002) 667-677
32. 164-mediated inflammation is required for pathological but not physiological ischemia induced retinal neovascularization. J Exp Med 198 (2003) 483-489
33. Ki-I Y., Arimura N., Noda Y., et al. Stromal derived factor-1 and inflammatory cytokines in retinal vein occlusion. Curr Eye Res 32 (2007) 1065-1072
34. Neuhaus T., Steir S., Totzke G., et al. Stromal cell-derived factor a (SDF-1a) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif 36 (2003) 75-86
35. Butler J.M., Guthrie S.M., Koc M., et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Inves 115 (2005) 86-93
36. Brooks H.L., Caballero S., Newell C.K., et al. Vitreous levels of vascular endothelial growth factor and stromal-derived growth factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of Triamcinolone. Arch Ophthalmol 122 (2004) 1801-1807
37. Ullian M.E. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 41 (1999) 55-64
38. Cekic O., Bardak Y., and Tig S.U. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema. Int Ophthalmol 27 (2007) 313-319
39. Jonas J.B. Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions. Br J Ophthalmol 91 (2007) 1711-1712
40. Hollander H., Makarov F., Dreher Z., et al. Structure of the macroglia of the retina: sharing and division of labor between astrocytes and Muller cells. J Comp Neuro 313 (1991) 587-603
41. Celik T., Iyisoy A., Yuksel C.U., et al. The prognostic significance of coronary collaterals in patients with ischemic heart disease: An essential response to ischemia. Int J Cardiol (2008) Forthcoming
42. Genevois O., Paques M., Simonutti M., et al. Microvascular remodeling after occlusion-recanalization of a branch retinal vein in rats. Invest Ophthalmol Vis Sci 45 (2004) 594-600
43. Peiris S.J., and Hill D.W. Collateral vessels in branch retinal vein occlusion. Trans Ophthalmol Soc UK 102 (1982) 178-181
44. Danis R.P., Bingaman D.P., Yang Y., and Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103 (1996) 2099-2104
45. Gillies M.C., Simpson J.M., Billson F.A., et al. Safety of an intravitreal injection of triamcinolone. Results from a randomized clinical trial. Arch Ophthalmol 122 (2004) 336-340